跳至主要内容
临床试验/NCT04899141
NCT04899141进行中(未招募)不适用

Prospective Registry of ihtDEStiny® Coronary Stent in Regular PCI Practice

Fundación EPIC20 个研究点 分布在 2 个国家目标入组 400 人开始时间: 2021年10月29日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
400
试验地点
20
主要终点
Death

研究概览

简要总结

Prospective registry intended to evaluate clinical outcomes of ihtDEStiny drug eluting coronary stent.

详细描述

Prospective registry intended to evaluate clinical outcomes of ihtDEStiny drug eluting coronary stent use in real-world percutaneous coronary intervention

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ≥18 years old
  • PCI and stent implantation indication according to ESC Myocardial Revascularization Guidelines
  • 1 or more stenosis at native coronary anatomy, in a 2-4mm vessel size, where 1 or more ihtDEStiny® drug eluting stent were implanted (or attempted to be implanted).
  • Informed consent signed after PCI

排除标准

  • Patient refusal to participate in the study
  • Pregnancy
  • Other DES implantation during index PCI, or 30 days before of after index PCI
  • PCI at surgical grafts
  • PCI for in-stent restenosis
  • Killip class 3-4 Acute Coronary Syndromes (ACS)
  • High bleeding risk with dual antiplatelet intolerance for at least 3 months (or 6 months for ACS PCI)
  • Allergy or hypersensitivity to sirolimus
  • Patients requiring surgery (cardiac or non-cardiac) in the next 3 months after index PCI
  • Patients with life expectancy <2 years
  • Patients included in other trials or clinical studies

研究组 & 干预措施

Coronary Artery Disease

干预措施: Percutaneous Coronary Intervention (Device)

结局指标

主要结局

Death

时间窗: 2 years

Death

Target Lesion Failure (TLF)

时间窗: 2 years

Rate of target lesion failure

Target vessel myocardial infarction

时间窗: 2 years

Target vessel myocardial infarction

Target lesion revascularization (TLR)

时间窗: 2 years

Target lesion revascularization (TLR)

Cardiovascular Death

时间窗: 2 years

Cardiovascular Death

Target lesion revascularization (TLR)

时间窗: 5 years

Target lesion revascularization (TLR)

Cardiovascular Death

时间窗: 5 years

Cardiovascular Death

Target Lesion Failure (TLF)

时间窗: 5 years

Rate of target lesion failure

Death

时间窗: 5 years

Death

Target vessel myocardial infarction

时间窗: 5 years

Target vessel myocardial infarction

次要结局

  • Stent thrombosis(2 years)
  • Major Adverse Cardiovascular Event (MACE)(2 years)
  • Patient Oriented Composite Event(2 years)
  • Device success(During procedure)
  • Procedural success(3 days)
  • Target Vessel Failure (TVF)(2 years)
  • Severe BARC Bleeding(2 years)
  • Stent thrombosis(5 years)
  • Target Vessel Failure (TVF)(5 years)
  • Major Adverse Cardiovascular Event (MACE)(5 years)
  • Patient Oriented Composite Event(5 years)
  • Severe BARC Bleeding(5 years)

研究者

发起方
Fundación EPIC
申办方类型
Other
责任方
Sponsor

研究点 (20)

Loading locations...

相似试验

Prospective Registry of ihtDEStiny® Coronary Stent... | 临床试验